Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia A
Clinical trial NCT02941354 · COMPLETED
Trial details
- NCT number
- NCT02941354
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-10
- Primary completion
- 2017-06-20
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.